Zydus Launches World's First Nivolumab Biosimilar 'Tishtha' in India
Zydus Lifesciences has launched Tishtha, the world’s first biosimilar of the immunotherapy drug nivolumab, in India, aimed at expanding access to advanced cancer care by offering the treatment at nearly one-fourth the cost of the reference product for patients with multiple cancer types.
- Market | 23/01/2026 | By News Bureau
Interviews
Swati Patel, Manager, Allpharm
Swati Patel, Manager, Allpharm discusses with Pharma Industrial India how the company is driving adoption of South Korean pharmaceutical machinery in India through competitive pricing, versatile solutions and robust...
Rahul Jaiswal, Account Manager, India, MA micro automation
Rahul Jaiswal, Account Manager–India, MA micro automation, explains to Pharma Industrial India how the Germany-based company is establishing its footprint in India, emphasising the growing demand for quality-f...
Prasad Gupta, Senior Manager, Marketing, Standard Group of Companies
Prasad Gupta, Senior Manager- Marketing, Standard Group of Companies, in an exclusive interview, shares insights with Pharma Industrial India, about the innovative approach to pharmaceutical machinery, highlighting ...
Articles
Sustainable Manufacturing for Pharma: Economic and Environmental Impact of Single-Use Systems
Falgun Jani, Business Head – India, Freudenberg Medical, explores the growing role of Single-use Systems (SUS) in enabling sustainable pharmaceutical manufacturing, highlighting their economic advantages, oper...
From Reactive Care to Predictive Pharma: Indian AI Shift by 2026
Tushar Dhawan, Partner, Plus91Labs, explains how India’s pharmaceutical industry is transitioning from a reactive, volume-driven model to a predictive, AI-powered ecosystem—highlighting the role of agent...
Shimadzu Leads Smarter Analytics Through AI-Led Innovations in Chromatography and Mass Spectrometry
Shimadzu is incorporating Analytical Intelligence (AI) and advanced software tools to streamline chromatography and mass spectrometry workflows, reduce manual intervention, and support regulatory-compliant method de...
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Market
- - Syngene International Q3 FY26 Revenue Slips Three Percent; Profit Impacted by One-Off Gratuity Provision
- - Dr Reddy's Q3 FY26 Net Profit Falls Fourteen Percent Despite Revenue Growth
- - G Square Backs Serres in Majority Acquisition to Drive Global Growth
- - Lupin Partners with Galenicum to Commercialise Injectable Semaglutide
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy